Trustmark National Bank Trust Department bought a new position in MetLife, Inc. (NYSE:MET – Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 2,722 shares of the financial services provider’s stock, valued at approximately $225,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in MET. Swedbank AB purchased a new position in MetLife in the first quarter worth $131,456,000. Acadian Asset Management LLC boosted its position in MetLife by 7,837.0% during the second quarter. Acadian Asset Management LLC now owns 1,129,353 shares of the financial services provider’s stock valued at $79,250,000 after buying an additional 1,115,124 shares during the period. Dimensional Fund Advisors LP boosted its position in MetLife by 22.4% during the second quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider’s stock valued at $378,799,000 after buying an additional 988,666 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its position in MetLife by 79.1% during the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,726,209 shares of the financial services provider’s stock valued at $142,378,000 after buying an additional 762,291 shares during the period. Finally, Public Sector Pension Investment Board boosted its position in MetLife by 347.4% during the second quarter. Public Sector Pension Investment Board now owns 432,887 shares of the financial services provider’s stock valued at $30,384,000 after buying an additional 336,127 shares during the period. 89.81% of the stock is currently owned by hedge funds and other institutional investors.
MetLife Price Performance
MET stock opened at $85.35 on Friday. MetLife, Inc. has a 52 week low of $62.15 and a 52 week high of $86.94. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The company has a fifty day simple moving average of $82.27 and a two-hundred day simple moving average of $75.91. The firm has a market capitalization of $59.09 billion, a P/E ratio of 17.21, a price-to-earnings-growth ratio of 0.75 and a beta of 1.05.
MetLife Announces Dividend
Analyst Upgrades and Downgrades
Several analysts have issued reports on the stock. Jefferies Financial Group upped their price target on shares of MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 27th. StockNews.com raised shares of MetLife from a “hold” rating to a “buy” rating in a research note on Tuesday, November 12th. Piper Sandler upped their price objective on shares of MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. Barclays lowered their price objective on shares of MetLife from $91.00 to $90.00 and set an “overweight” rating for the company in a research note on Thursday, October 31st. Finally, Morgan Stanley lowered their price objective on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a research note on Monday, August 19th. Fourteen analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $88.46.
Check Out Our Latest Stock Report on MetLife
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- Options Trading – Understanding Strike Price
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- What Investors Need to Know to Beat the Market
- TJX Companies Stock Poised to Hit a New High This Year
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.